VACCINE Presents to the Anti Terrorism Advisory Council
April 1, 2010
On April 1st, VACCINE’s David Ebert was the guest speaker at the Anti Terrorism Advisory Council (ATAC) meeting for the Northern District of Illinois. ATAC’s three fold objective is to prevent, disrupt and defeat terrorist operations before they occur by: developing and implementing a full range of resources available to investigate terrorist incidents, bringing their perpetrators to justice; and vigorously prosecuting those who have committed, or intend to commit, terrorist acts in the United States. Accompanied by Joe Kielman, David discussed the VACCINE Center of Excellence and its mission.
The audience was comprised of mid-to-senior-level representatives of federal, state, and local law enforcement, as well as homeland security organizations with counterterrorism responsibilities. Audience members ranging from the U.S. Attorney’s Offices Intelligence Specialists to the Chicago Police Department expressed interest in potential collaborations. One such opportunity would coordinate and leverage VACCINE’s expertise in visualization sciences with a project currently funded by the Department of Justice. The presentation was a success that is sure to lead to future endeavors and successful partnerships.
September 26, 2014
Officials of a pharmaceutical startup based on a Purdue University innovation say their company is creating prefabricated drug dosages that could be used by compounding pharmacists to support patient-centered medicine.Read Full Story
September 25, 2014
Purdue researchers have discovered the structure of the enzyme that makes cellulose, a finding that could lead to easier ways of breaking down plant materials to make biofuels and other products and materials.Read Full Story
September 17, 2014
A Purdue startup is commercializing a technology that could reduce the symptoms and pain of neurological disease and injury, including multiple sclerosis, neuropathic pain and Parkinson's disease.Read Full Story